The route to personalized medicine in bladder cancer: where do we stand?
- PMID: 25634607
- DOI: 10.1007/s11523-015-0357-x
The route to personalized medicine in bladder cancer: where do we stand?
Abstract
Recent advances in molecular biology and drug design have described novel targets in bladder cancer. EGFR, fibroblast growth factor receptor (FGFR), VEGFR, phosphoinositide 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway, PD-1, cyclooxygenase 2 (COX-2), Aurora kinase A, and miRNA are just examples of these opening frontiers. In addition, epithelial to mesenchymal transition (EMT) and cancer stem cells (CSCs) are promising candidates for future therapeutic approaches. Novel agents, combination, and sequences are emerging from the 747 clinical studies presently in course in bladder cancer to optimize patient outcomes. This report describes the emerging targets and provides an update on ongoing phase I, II, and III trials and preliminary results on targeted agents, used alone, in sequences, or in combination for patients with bladder cancer.
Similar articles
-
Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.Drug Des Devel Ther. 2015 Jan 17;9:575-601. doi: 10.2147/DDDT.S75221. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 25632225 Free PMC article.
-
A place for precision medicine in bladder cancer: targeting the FGFRs.Future Oncol. 2016 Oct;12(19):2243-63. doi: 10.2217/fon-2016-0042. Epub 2016 Jul 6. Future Oncol. 2016. PMID: 27381494 Free PMC article. Review.
-
Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.Drug Des Devel Ther. 2015 Mar 2;9:1293-318. doi: 10.2147/DDDT.S74964. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 25767376 Free PMC article.
-
Hesperidin induces apoptosis and triggers autophagic markers through inhibition of Aurora-A mediated phosphoinositide-3-kinase/Akt/mammalian target of rapamycin and glycogen synthase kinase-3 beta signalling cascades in experimental colon carcinogenesis.Eur J Cancer. 2014 Sep;50(14):2489-507. doi: 10.1016/j.ejca.2014.06.013. Epub 2014 Jul 18. Eur J Cancer. 2014. PMID: 25047426
-
Systemic therapy of metastatic bladder cancer in the molecular era: current status and future promise.Expert Opin Investig Drugs. 2010 Jul;19(7):875-87. doi: 10.1517/13543784.2010.496450. Expert Opin Investig Drugs. 2010. PMID: 20528482 Review.
Cited by
-
Key Role of Obesity in Genitourinary Tumors with Emphasis on Urothelial and Prostate Cancers.Cancers (Basel). 2019 Aug 22;11(9):1225. doi: 10.3390/cancers11091225. Cancers (Basel). 2019. PMID: 31443386 Free PMC article. Review.
-
Stem-Like Signature Predicting Disease Progression in Early Stage Bladder Cancer. The Role of E2F3 and SOX4.Biomedicines. 2018 Aug 2;6(3):85. doi: 10.3390/biomedicines6030085. Biomedicines. 2018. PMID: 30072631 Free PMC article. Review.
-
Chronic inflammation in urothelial bladder cancer.Virchows Arch. 2015 Dec;467(6):623-633. doi: 10.1007/s00428-015-1820-x. Epub 2015 Aug 12. Virchows Arch. 2015. PMID: 26263854
-
Bladder Cancer Stem-Like Cells: Their Origin and Therapeutic Perspectives.Int J Mol Sci. 2015 Dec 29;17(1):43. doi: 10.3390/ijms17010043. Int J Mol Sci. 2015. PMID: 26729098 Free PMC article. Review.
-
The importance of personalized medicine in urological cancers.J Diabetes Metab Disord. 2021 Jun 29;21(1):841-852. doi: 10.1007/s40200-021-00824-0. eCollection 2022 Jun. J Diabetes Metab Disord. 2021. PMID: 35673449 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
